PFO
MDXG icon

Pathstone Family Office’s MiMedx Group MDXG Stock Holding History

Pathstone Family Office’s Portfolio MDXG Stock Details MDXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$93.5K Buy
+12,819
New +$95.5K ﹤0.01% 1591
2021
Q1 		– Sell
-6,000
Closed -$54K – 1060
2020
Q4 		$54K Buy
+6,000
New +$43.2K ﹤0.01% 504

Other funds holding MDXG

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CC
Cannell Capital Alta, Wyoming $149M AUM 39.81% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
RB
Richmond Brothers Jackson, Michigan $192M AUM 23.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Pathstone Family Office's MDXG Position: Q3 2023 in Review

Pathstone Family Office opened a new position in MiMedx Group (MDXG) in Q3 2023: 12,819 shares worth $93.5K. The stake represents ﹤0.01% of the portfolio and ranks #1591 among its holdings. This is a return to the name: Pathstone Family Office previously reported a position in MDXG as recently as Q4 2020.

Pathstone Family Office first reported a position in MDXG in Q4 2020 and has held it in 2 quarters since. 185 funds tracked by Wall St. Rank hold MDXG as of Q3 2023.

  • Pathstone Family Office held 12,819 shares of MiMedx Group worth $93.5K as of Q3 2023.
  • MiMedx Group was a new Pathstone Family Office position in Q3 2023.
  • MiMedx Group made up ﹤0.01% of Pathstone Family Office's portfolio in Q3 2023, its #1591 holding.
  • Pathstone Family Office first reported a position in MiMedx Group in Q4 2020 and has held it in 2 quarters since.
  • 185 funds tracked by Wall St. Rank held MiMedx Group as of Q3 2023.

Based on Pathstone Family Office's 13F filing for Q3 2023, filed 8 Nov 2023.